Northern Trust Corp Biodesix Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Biodesix Inc stock. As of the latest transaction made, Northern Trust Corp holds 43,764 shares of BDSX stock, worth $63,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,764

Previous 43,764 -0.0%

Holding current value

$63,457

Previous $66,000 16.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.21 - $1.71 $13,260 - $18,739	10,959 Added 33.41%	43,764 $66,000
Q1 2024 May 14, 2024	BUY	$1.35 - $2.12 $2,284 - $3,587	1,692 Added 5.44%	32,805 $46,000
Q4 2023 Feb 13, 2024	SELL	$1.2 - $2.13 $3,592 - $6,377	-2,994 Reduced 8.78%	31,113 $57,000
Q3 2023 Nov 13, 2023	SELL	$1.04 - $1.74 $17,373 - $29,066	-16,705 Reduced 32.88%	34,107 $56,000
Q1 2023 May 15, 2023	BUY	$1.52 - $2.5 $53,306 - $87,675	35,070 Added 222.78%	50,812 $94,000
Q3 2022 Nov 14, 2022	SELL	$1.24 - $2.89 $14,753 - $34,385	-11,898 Reduced 43.05%	15,742 $20,000
Q2 2022 Aug 12, 2022	SELL	$1.32 - $2.12 $99,608 - $159,977	-75,461 Reduced 73.19%	27,640 $45,000
Q1 2022 May 13, 2022	SELL	$1.69 - $5.81 $4,285 - $14,734	-2,536 Reduced 2.4%	103,101 $174,000
Q4 2021 Feb 08, 2022	BUY	$4.09 - $8.67 $2,961 - $6,277	724 Added 0.69%	105,637 $558,000
Q3 2021 Nov 15, 2021	SELL	$6.6 - $12.78 $13,266 - $25,687	-2,010 Reduced 1.88%	104,913 $862,000
Q2 2021 Aug 13, 2021	BUY	$12.14 - $20.35 $789,937 - $1.32 Million	65,069 Added 155.47%	106,923 $1.41 Million
Q1 2021 May 12, 2021	SELL	$16.87 - $31.21 $13,141 - $24,312	-779 Reduced 1.83%	41,854 $849,000
Q4 2020 Feb 11, 2021	BUY	$10.89 - $20.16 $464,273 - $859,481	42,633 New	42,633 $860,000

Others Institutions Holding BDSX

# of Institutions

Shares Held

62.3M

Call Options Held

2.6K

Put Options Held

10.1K

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $58M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Biodesix Inc Transaction History